Conditioning of insulin responses: A high risk- high gain intervention for diabetes type-2

eiden University, Leiden University Medical Center0 个研究点目标入组 64 人开始时间: 待定最近更新: 2024年2月28日

试验速览

暂无简介。

•- Mentally capable and older than 18 years old;
•- Diagnosis of diabetes type-2
•- Take metformin as a treatment and/or participate in a lifestyle intervention (e.g., diet) to control their diabetes.
•Healthy controls:
•- Mentally capable and older than 18 years old;

•- Use of insulin or insulin stimulating medications;
•- Use of medication that influences glucose metabolism, for example, corticosteroid
•medication, chemotherapy, beta-blockers;
•- Diagnosis of an acute not-infectious disease (degenerative diseases, malignant neoplasms such as cancer, diabetes type-1, auto-immune diseases);
•- Diagnosis of an acute infectious diseases (such as meningitis, hepatitis B, bacterial pneumonia);
•- Current diagnosis of a mental disorder;
•- Chronic and/or acute rhinitis, anatomic deviations of the nose;
•- Substance abuse (e.g., drugs or alcohol);
•- Pregnancy or an intention to get pregnant.
•Healthy controls:
•-Diagnosis of diabetes type-1 or type-2
•-Use of insulin or insulin stimulating medications;
•-Use of medication that influences glucose metabolism, for example, corticosteroid
•-medication, chemotherapy, beta-blockers;
•-Diagnosis of an acute not-infectious disease (degenerative diseases, malignant neoplasms such as cancer, diabetes type-1, auto-immune diseases);
•- Diagnosis of an acute infectious diseases (such as meningitis, hepatitis B, bacterial pneumonia);
•- Current diagnosis of a mental disorder;
•- Chronic and/or acute rhinitis, anatomic deviations of the nose;
•- Substance abuse (e.g., drugs or alcohol);
•- Pregnancy or an intention to get pregnant.

发起方

eiden University, Leiden University Medical Center